XOMA Royalty (XOMA) Current Taxes (2017 - 2024)

XOMA Royalty (XOMA) reported Current Taxes of $280000.0 for Q4 2024, up 207.69% sequentially from $91000.0 in Q4 2021.

XOMA Royalty (XOMA) Current Taxes (2017 - 2024) Analysis & Trends

XOMA Royalty (XOMA) has 4 years of Current Taxes data on file, last reported at $280000.0 in Q4 2024.

  • For the quarter ending Q4 2024, Current Taxes changed N/A year-over-year to $280000.0; the trailing twelve-month figure through Dec 2024 stood at $280000.0 (changed N/A YoY), and the FY2024 full-year result was $280000.0, changed N/A from the prior year.
  • Current Taxes grew to $280000.0 in Q4 2024, from $91000.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $280000.0 in Q4 2024 to a low of $91000.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 63.52 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 49.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 XOMA Royalty 478.42 Mn 412.34 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 280,000.00
Dec 31, 2021 91,000.00
Mar 31, 2018 1.67 Mn
Dec 31, 2017 1.64 Mn
Sep 30, 2017 1.71 Mn